Summitry LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Summitry LLC's AMGN Position: Q2 2026 in Review
Summitry LLC increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $454K and bringing the position to 75,057 shares worth $27.2M. The position accounts for 0.89% of the portfolio, ranked #41.
Summitry LLC first reported a position in AMGN in Q2 2020 and has held it in 8 quarters since. 1,221 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Summitry LLC held 75,057 shares of Amgen worth $27.2M as of Q2 2026.
- Summitry LLC bought 1,325 Amgen shares in Q2 2026, an estimated $454K.
- Amgen made up 0.89% of Summitry LLC's portfolio in Q2 2026, its #41 holding.
- Summitry LLC first reported a position in Amgen in Q2 2020 and has held it in 8 quarters since.
- 1,221 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.